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ABSTRACT
As reported in our previous studies, dithiaden (an antagonist of histamine H1-receptor, used clinically as an anti-allergic or anti-emetic 
drug) in a concentration range of 5×10–5–10–4 M decreased the production of reactive oxygen species by phagocytes. In this study 
we investigated the influence of dithiaden on nitric oxide (NO) production by LPS-stimulated macrophages. 
The cell viability in the presence of 10–4–5×10–5 M dithiaden was evaluated by an ATP-test. RAW 264.7 cells (2.5×106/well) were pre-
incubated with dithiaden for 60 mins and subsequently stimulated with 0.1 µg/ml of bacterial lipopolysaccharide. After incubating 
for 24 hours the NO production was determined spectrophotometrically using Griess reaction as a concentration of nitrites (the end 
product of NO metabolism) accumulated in the cell supernatants. The expression of inducible nitric oxide synthase (iNOS) in cell-
lysates was evaluated using Western blot analysis. Scavenging properties of dithiaden against NO were evaluated amperometrically. 
Our data demonstrate that dithiaden in the concentration of 5×10–5 M (approved by ATP test as non toxic) caused a significant 
decrease in the accumulation of nitrites, and in addition, this decline was followed by a marked reduction of iNOS protein expression. 
Amperometrical analysis did not show any scavenging properties of dithiaden against NO. 
From this data it can be suggested that the inhibition effect of dithiaden on macrophage NO production is caused exclusively by the 
suppression of iNOS protein expression.
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drug (De Vos, 1999). The suppresive effects of this group of 
drugs on histamine secretion from mast cells and basophils 
are well known. Experiments suggested that the chemical 
structure of H1-antihistamines, namely positively charged 
lipophilic molecules, allows them to associate with the cell 
membrane. Moreover, they are able to inhibit the activity of 
calcium-dependent enzymes, affect the calcium mobiliza-
tion and the discharge of intracellular calcium stores as 
being responsible for various effects including histamine 
secretion, eicosanoids or reactive oxygen metabolites gen-
eration (Church, 2001; Lullmann et al., 1980). The produc-
tion of reactive oxygen and nitrogen species by phagocytes 
belongs to the important microbicidal mechanisms of fight 
against pathogenic microorganisms, bacterias, tumor cells 
etc., in the process of inflammation. Normal inflammatory 
responses are self-limited by a process that involves the 
downregulations  of  pro-inflammatory  proteins  and  the 
upregulations  of  anti-inflammatory  proteins  (Lawrence 
et al., 2002). But chronic inflammation accompanied by a 
rise in oxidative stress with an overproduction of reactive 
oxygen and nitrogen species could contribute to the patho-
genesis of many inflammatory diseases, such as bronchitis 
or rheumatoid arthritis. Whereas the effect of dithiaden on 
Abbreviations 
ATP   - adenosine triphosphate
DMEM   - Dulbecco’s Modified Eagle’s Medium
FBS   - fetal bovine serum
iNOS   - inducible nitric oxide synthase
LPS   - lipopolysaccharide
NO   - nitric oxide
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SDS   - sodium dodecyl sulfate
Introduction
H1-antihistamine  dithiaden  (4[3-dimethylamino 
(propylidiene)]-4,9dihydrothieno-(2,3b)benzo-[e]thiepin) is 
a member of the 1st class of histamine H1-receptor block-
ers and is used clinically as an anti-allergic or anti-emetic 
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the production of reactive oxygen species is relatively well 
described (Kralova et al., 2006; Nosal et al., 2002; Nosal et al., 
2006), the information about the role of dithiaden on reac-
tive nitrogen species generation is insufficient. Therefore, 
the present study investigated the effects of dithiaden on 
nitric oxide (NO) production by murine macrophages like 
cells RAW 264.7 stimulated by lipopolysaccharide and also 
tries to detect the direct scavenging properties of dithiaden 
against NO in a cell free system.
Materials and methods
Materials
Dithiaden (Zentiva, Czech Rep.) was dissolved in distilled 
water and the stock solution 3×10–3M was stored in –20 °C. 
Lipopolysaccharide (LPS) from Escherichia coli serotype 
0111:B4 (Sigma-Aldrich, USA) was dissolved in PBS and the 
stock solution 1mg/ml was stored in –20 °C. Other chemi-
cals were purchased from local distributors. 
RAW 264.7 cells
A  murine  leukaemic  macrophage-like  RAW  264.7  cells 
(ATCC,  USA)  were  grown  in  plastic  culture  flasks  in 
Dulbecco’s  Modified  Eagle’s  Medium  (DMEM)  supple-
mented with heat-inactivated 10% fetal bovine serum (FBS), 
gentamycin, glucose and NaHCO3 in a CO2 incubator (5% 
CO2 and 95% of air humidity) at 37 °C. Cells were seeded 
at an initial density of 2.5×106 cells/well in a 6-well tissue 
culture plates and preincubated with dithiaden for 60 min. 
Cells were then stimulated with LPS (0.1 µg/ml) and incu-
bated 24 h. Non-treated cells were used as the control. Cell 
supernatants were used for the determination of nitrite 
concentration, cells were used for the measurement of ATP 
content and iNOS protein expression.
ATP test of cell viability 
The viability of RAW 264.7 cells was tested by the com-
mercial ATP cellular kit (Biothema, Sweden). Cells were 
incubated for 24 hours with 10–4 and 5×10–5 M dithiaden, 
supernatant was removed and cells were lyzed by Somatic 
cell  ATP  releasing  reagent  (Sigma  Aldrich,  USA).  The 
volume of 50 µl of lyzate were mixed with a 20 µl ATP 
reagent SL containing D-luciferin, luciferase and stabiliz-
ers. Intracellular ATP contents were determined lumino-
metrically using luminometer Orion II. (Berthold Detection 
Systems GmbH, Germany). 
Determination of nitrite production by cells
Detection  of  accumulated  nitrites  (NO2
–)  in  the  cell 
supernatants was performed using the Griess reagent as 
described previously (Migliorini et al., 1991). 150 μl of the 
cell supernatant was incubated with 150 μl Griess reagent 
(Sigma-Aldrich, USA) for 15 min in a dark at room tem-
perature and the absorbance was measured at 546 nm on 
a Spectra Rainbow UV/Vis microplate reader (SLT Tecan, 
Germany). The concentrations of nitrites were derived by 
regression analysis using serial dilutions of sodium nitrite 
as a standard. 
Determination of iNOS protein expression by cells
Cells were lysed with 1% SDS lysing buffer with the addition 
of  1%  phenylmethanesulphonylfluoride.  Protein  volume 
in cell samples was determined using commercial BCA 
protein assay (Pierce, USA), proteins (22 μg) were separated 
by 7.5% SDS-PAGE and then transferred to a polyvinylidene 
difluoride membrane in a buffer containing Tris-glycine 
and 20% methanol. Protein was labeled using mouse anti-
body (1:1000) specific to iNOS (Becton – Dickinson, USA) 
and HRP-conjugated goat anti-mouse antibody (1:2000) 
(ECL™  Anti-mouse  IgG,  Amersham,  Biosciences,  USA), 
subsequently immunoreactive bands were visualised using 
ECL detection reagent (Detection reagents kit, Pierce, USA).
Amperometrical detection of NO scavenging
The  measurement  of  NO  scavenging  was  performed 
amperometrically using ISO-NO Mark II NO meter (World 
Precision Instruments, Inc. USA). The measurement was 
practised  using  NO  standard  solutions  prepared  with 
pure NO gas. Preparation of 2 mM NO stock solution was 
described earlier (Feelisch and Kelm, 1991). 1 µl of NO stock 
solution was injected either into the 10 ml of PBS in a glass 
vial or into the 10 ml of PBS with the addition of 5×10–5 M 
dithiaden and the signal was measured for 10 min. Then the 
integrals of control curve and sample curve were calculated 
and the scavenging activity of the dithiaden was evaluated.
Statistical evaluation
Data are expressed as the mean ± standard error of the mean 
(SEM) of at least 3 independent experiments, that were run 
in duplicates. Results were analysed by Student’s two-tailed 
t-test using Statistica software (StatSoft, USA), values below 
0.05 (*) were considered statistically significant.
Results
Nitrite production was dependent on the activating state 
of RAW 264.7 cells. While only very low concentrations of 
nitrites (0.5–2 µM) were detected in non-stimulated cells, the 
cells stimulated with 0.1 µg/ml LPS generated 28.2 ± 2.52 µM 
(mean ± SEM) of nitrites. The value of nitrite accumula-
tion after LPS-stimulation was used as a positive control. 
Figure 1 demonstrates that the lowest concentration 
of  dithiaden  (10–5 M)  did  not  exert  ability  to  modulate 
nitrite production in cells stimulated with LPS. 5×10–5 M 
dithiaden  significantly  decreased  the  nitrite  concentra-
tion (56.06 ± 3.34% of positive control level). Dithiaden in 
concentration 10–4 M also affected the nitrite accumulation 
(20.93 ± 2.19% of positive control level) in LPS-stimulated 
cells. However, this concentration of dithiaden also caused a 
significant decline in intracellular ATP concentrations (data 
not shown) and exerted a strong cytotoxic effect on RAW 
264.7 after 24 hours of incubation. Therefore, the 5×10–5 M 
concentration of dithiaden which proved to be non toxic but 
still effective was used for the following experiments with cells.
The possibilty that the decrease in nitrite concentration 
was induced by a suppressioon of iNOS protein expression 
was verified in subsequent experiments. Figure 2 shows 216
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that 5×10–5 M dithiaden inhibited the iNOS protein levels 
in cell lysates to 59.88 ± 4.03% of positive control level (cells 
stimulated with LPS). 
Dithiaden was further tested for scavenging NO by direct 
amperometric analysis using a carbon electrode selective 
for NO. Dithiaden in the 5×10–5 M concentration did not 
approve any scavenging properties against nitric oxide in 
PBS as shown in Figure 3. 
Figure 1. The effect of dithiaden on the concentration of nitrites 
in the supernatant collected from RAW 264.7 cells stimulated by 
0.1 µM LPS after a 24 hour incubation period at 37°C in comparison 
with non-treated cells (control). Data are expressed as percentages 
of the control. Values represent mean ± SEM, n=3. Asterisks show 
significant differences as compared to control, p<0.05 was consid-
ered as statistically significant as compared to control. 
Figure  2.  The  expression  of  iNOS  in  the  cell  lysates  from  RAW 
264.7 cells stimulated by 0.1 µM LPS after 24 hour incubation with 
5×10–5 M dithiaden at 37 °C in comparison with non-treated cells 
(control). Data are expressed as percentages of the control. Values 
represent mean ± SEM, n=3. Asterisks show significant differences 
as compared to control, p<0.05 was considered as statistically sig-
nificant as compared to control. 
Figure  3. The  effect  of  5×10–5 M  dithiaden  against  nitric  oxide 
(NO) evaluated amperometrically. The electrochemical signal was 
induced by the addition of the NO stock solution as described in 
the text. Data are expressed as mean ± SEM, n = 3. 
Discussion 
Althought  the  number  of  recently  published  results 
(Jancinova et al., 2006; Kralova et al., 2006; Nosal et al., 
2002; Nosal et al., 2005; Nosal et al., 2006) have demon-
strated that dithiaden and other H1-antihistamines play 
a very important role in the regulation of reactive oxygen 
species production and also in the regulation of myeloper-
oxidase activity (Kralova et al., 2008), any information about 
the effect of H1-antihistamines on the generation of reactive 
nitrogen species is yet to be determined. We consequently 
investigated the role of dithiaden in the regulation of nitric 
oxide  production  in  macrophages.  Detection  of  iNOS 
protein expression and nitrite concentration are reliable 
methods for verifying NO production by cells. NO is gener-
ated by several types of cells in an L-arginine – pathway in 
the presence of nitric oxide synthases (NOS) (Moncada and 
Higgs, 1993; Palmer et al., 1987). iNOS is mainly expressed 
in macrophages in response to inflammatory stimuli, e.g. 
Gram-negative bacterial lipopolysaccharide or proinflam-
matory cytokines (IL-1 or TNF-α) (Stuehr and Marletta, 
1985). We used this phenomenon for the in vitro experi-
ments with a murine macrophage cell line RAW 264.7. We 
suggested that dithiaden (10–4 M and 5×10–5 M) caused 
a significant decrease in nitrite accumulation and also in 
iNOS protein expression in LPS-treated cells. However, only 
the 5×10–5 M concentration of dithiaden was non-toxic.
NO can be a double-edged sword. On one hand, NO is 
an important molecule involved in the regulation of many 
physiological  and  microbicidal  processes.  On  the  other 
hand,  its  overproduction  is  included  in  several  chronic 217
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inflammatory diseases such as bronchitis, osteoarthritis 
or rheumatoid arthritis (McInnes et al., 1996). It is evident 
from our results, dithiaden does not directly scavenge nitric 
oxide generated in chemical system, this H1-antihistamine 
drug exerted significant inhibitory effects on the nitric oxide 
production by a murine macrophage cell line RAW 264.7. It 
can be concluded that this inhibition of nitric oxide produc-
tion was caused by a decrease in iNOS expression.
We suggest that dithiaden by decreasing the nitric oxide 
production might contribute to the treatment of chronic 
inflammatory processes.
Aknowledgement
This  study  was  conducted  under  the  research  plans 
AVOZ50040507  and  AVOZ50040702  and  supported  by 
grants 1QS500040507 GA AS CR, GA CR 524/08/1753 and 
VEGA 2/7019/27.
Jancinova V, Drabikova K, Nosal R, Holomanova D (2006) Extra- and intracellular 
formation of reactive oxygen species by human neutrophils in the presence 
of pheniramine, chlorpheniramine and brompheniramine. Neuro Endocrinol 
Lett 27 Suppl 2: 141–143.
Kralova J, Ciz M, Nosal R, Drabikova K, Lojek A (2006) Effect of H(1)-antihista-
mines on the oxidative burst of rat phagocytes. Inflamm Res 55 Suppl 1: 
S15–16.
Kralova J, Nosal R, Drabikova K, Jancinova V, Denev P, Moravcova A, et al. (2008) 
Comparative investigations of the influence of H1-antihistamines on the gen-
eration of reactive oxygen species by phagocytes. Inflamm Res 57 Suppl 1: 
S49–50.
Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid media-
tors and insights into the resolution of inflammation. Nat Rev Immunol 2: 
787–795.
Lullmann H, Plosch H, Ziegler A (1980) Ca replacement by cationic amphiphilic 
drugs from lipid monolayers. Biochem Pharmacol 29: 2969–2974.
McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, 
Weidner J, Mumford R, Liew FY (1996) Production of nitric oxide in the syno-
vial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184: 
1519–1524.
Migliorini P, Corradin G, Corradin SB (1991). Macrophage NO2
– production as a 
sensitive and rapid assay for the quantitation of murine IFN-gamma. J Immu-
nol Methods 139: 107–114.
Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 
329: 2002–2012.
Nosal R, Drabikova K, Ciz M, Lojek A, Danihelova E (2002) Effect of H1-antag-
onist Dithiaden on human PMN-leukocyte aggregation and chemilumines-
cence is stimulus-dependent. Inflamm Res 51: 557–562.
Nosal R, Drabikova K, Jancinova V, Petrikova M, Fabryova V (2005) Antiplatelet 
and antiphagocyte activity of H1-antihistamines. Inflamm Res 54 Suppl 1: 
S19–20.
Nosal R, Drabikova K, Jancinova V, Macickova T, Pecivova J, Holomanova D 
(2006) On the pharmacology and toxicology of neutrophils. Neuro Endocri-
nol Lett 27 Suppl 2: 148–151.
Palmer RM, Ferrige AG, Moncada S (1987). Nitric oxide release accounts for the 
biological activity of endothelium-derived relaxing factor. Nature 327: 524–
526.
Stuehr DJ, Marletta MA (1985) Mammalian nitrate biosynthesis: mouse macro-
phages produce nitrite and nitrate in response to Escherichia coli lipopoly-
saccharide. Proc Natl Acad Sci U S A 82: 7738–7742.
RefeReNceS
Bakker RA, Schoonus SB, Smit MJ, Timmerman H, Leurs R (2001) Histamine H(1)-
receptor activation of nuclear factor-kappa B: roles for G beta gamma- and 
G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol 
Pharmacol 60: 1133–1142.
De Vos C (1999) H1-receptor antagonists: effects on leukocytes, myth or reality? 
Clin Exp Allergy 29 Suppl 3: 60–63.
Feelisch M, Kelm M (1991) Biotransformation of organic nitrates to nitric oxide 
by vascular smooth muscle and endothelial cells. Biochem Biophys Res Com-
mun 180: 286–293.
Church MK (2001) H(1)-antihistamines and inflammation. Clin Exp Allergy 31: 
1341–1343.